Streetbeat News

Regulatory

PGEN

Precigen announced significant progress in the development of PRGN-2012 AdenoVerse immunotherapy for RRP treatment, planning a BLA submission for accelerated approval in 2H 2024. The company received FDA's Breakthrough Therapy Designation for PRGN-2012 and is advancing other studies, including PRGN-2009 in combination with pembrolizumab for cervical cancer, and PRGN-3006 and PRGN-3007 UltraCAR-T therapies. Financially, Precigen reported $62.9 million in cash and investments as of December 31, 2023, and a 16% reduction in SG&A costs year-over-year.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:11 pm

NYXH

Nyxoah announced that its DREAM US pivotal study met its primary endpoints. CEO Olivier Taelman stated they are finalizing the PMA application's fourth module and anticipate launching Genio in the U.S, pending FDA approval.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:06 pm

DSGN

Design Therapeutics, Inc. (DSGN) provided an update on its GeneTAC platform, highlighting progress in developing treatments for degenerative genetic diseases. Key updates include a new drug product for Friedreich Ataxia (FA), DT-216P2, with favorable pharmacokinetic and safety profiles, an IND clearance for DT-168 for Fuchs Endothelial Corneal Dystrophy (FECD), and a new program targeting Huntington's Disease (HD). The company reported a strong financial position with $281.8 million in cash and securities, supporting a five-year operating runway.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 8:02 pm

MNTS

Momentus Space has received U.S. Patent 11,936,335 for a 'Rollable Tape Spring Solar Array' designed for solar energy harvesting on spacecraft. This innovation could enhance the efficiency and flexibility of power generation in space, potentially impacting Momentus Space's offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 7:58 pm

QQQ

SPY

UUP

The upcoming Federal Open Market Committee (FOMC) meeting in March 2024 is highly anticipated for its 'dot plot' update, indicating potential future interest rate cuts. The December 2023 dot plot suggested readiness for rate cuts in 2024, with a projected federal funds rate midpoint of 4.6%. The March meeting's dot plot is crucial as it may confirm or adjust these expectations, impacting financial markets, particularly the SPDR S&P 500 ETF Trust (SPY), Invesco QQQ Trust (QQQ), and the Invesco DB USD Index Bullish Fund ETF (UUP).

Portfolio Pulse from Piero Cingari

March 19, 2024 | 7:56 pm

CXW

GEO

SPY

The White House has expressed fundamental disagreement with the Supreme Court's ruling on Texas border crossing, impacting companies involved in detention services and broader market indicators.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 7:54 pm

INTC

NVDA

Intel Corp (NASDAQ:INTC) shares dropped 2% to $41.86 amid broader semiconductor sector weakness due to the upcoming Federal Reserve's FOMC meeting and recent announcements by NVIDIA Corp. Investors are concerned about potential changes in interest rates following recent inflation data, which could affect future monetary policy decisions. Intel's dividend yield stands at 1.48% as of Mar. 19, 2024.

Portfolio Pulse from Henry Khederian

March 19, 2024 | 7:52 pm

ENVB

Enveric Biosciences Canada has been granted U.S. Patent #11931338 for nitrilated psilocybin derivatives and their usage methods. This development could potentially enhance the company's intellectual property portfolio and open new avenues in psychedelic-based treatments.

Portfolio Pulse from Charles Gross

March 19, 2024 | 7:33 pm

DWAC

SPY

Donald Trump has filed a legal brief with the U.S. Supreme Court, seeking immunity from prosecution for his attempts to overturn the 2020 election loss. This move is a significant escalation in his legal defense strategy and highlights the ongoing legal challenges facing the former president.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 7:20 pm

BA

The FAA Chief has issued a warning to Boeing, emphasizing that the company has no choice but to address and rectify its safety issues, as reported by NBC News.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 6:52 pm